These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 1250190

  • 1. [Control of the heparin induced bleeding risk in haemodialysis patients (author's transl)].
    Vogel GE, Kopp KF.
    Med Klin; 1976 Jan 16; 71(3):116-9. PubMed ID: 1250190
    [Abstract] [Full Text] [Related]

  • 2. [Theoretical basis and practical carrying out of an APTT control test for exact heparin monitoring (author's transl)].
    Vogel GE.
    Med Klin; 1977 Feb 11; 72(6):207-11. PubMed ID: 840137
    [Abstract] [Full Text] [Related]

  • 3. [Heparin dosage in chronic hemodialysis (author's transl)].
    Vogel GE, Hansen W, Goldmann FL, Kopp KF.
    Med Klin; 1977 Oct 07; 72(40):1617-23. PubMed ID: 916946
    [Abstract] [Full Text] [Related]

  • 4. [Hemodialysis without risk of hemorrhage. Introduction of an APTT bedside method for exact heparin monitoring--a review].
    Vogel GE.
    Fortschr Med; 1977 Oct 27; 95(40):2437-44. PubMed ID: 924326
    [Abstract] [Full Text] [Related]

  • 5. [Heparin kinetics and methods of heparinization during haemodialysis (author's transl)].
    Lopot F.
    Cas Lek Cesk; 1980 Feb 01; 119(5):139-44. PubMed ID: 7379103
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Inadvertent postdialysis anticoagulation due to heparin line locks.
    Pepper RJ, Gale DP, Wajed J, Bommayya G, Ashby D, McLean A, Laffan M, Maxwell PH.
    Hemodial Int; 2007 Oct 01; 11(4):430-4. PubMed ID: 17922740
    [Abstract] [Full Text] [Related]

  • 8. Monitoring of heparins in haemodialysis using an anti-factor-Xa-specific whole-blood clotting assay.
    Harenberg J, Haaf B, Dempfle CE, Stehle G, Heene DL.
    Nephrol Dial Transplant; 1995 Oct 01; 10(2):217-22. PubMed ID: 7753456
    [Abstract] [Full Text] [Related]

  • 9. [Individual dosage schedule of heparin therapy in chronic hemodialysis by analytic studies of blood coagulation].
    Gläser V, Anstadt M.
    Z Urol Nephrol; 1990 Mar 01; 83(3):133-40. PubMed ID: 2356667
    [Abstract] [Full Text] [Related]

  • 10. [Standardisation and quality control of the thromboplastin time (Quick test) (author's transl)].
    Beck EA.
    Ther Umsch; 1977 May 01; 34(5):347-9. PubMed ID: 867316
    [No Abstract] [Full Text] [Related]

  • 11. [Experiences with minimal intermittent heparinization in chronic dialysis patients].
    Kovác A, Hünicke G, Bierwisch H.
    Z Urol Nephrol; 1980 May 01; 73(5):353-9. PubMed ID: 7456802
    [Abstract] [Full Text] [Related]

  • 12. [Most frequent errors in the laboratory control of oral anticoagulation (author's transl)].
    Duckert F.
    Ther Umsch; 1977 May 01; 34(5):350-4. PubMed ID: 867317
    [No Abstract] [Full Text] [Related]

  • 13. Bleeding and thrombosis in high-risk renal transplantation candidates using heparin.
    Mathis AS, Davé N, Shah NK, Friedman GS.
    Ann Pharmacother; 2004 Apr 01; 38(4):537-43. PubMed ID: 14766999
    [Abstract] [Full Text] [Related]

  • 14. [Partial thromboplastin time (PTT) in the pediatric age group. Normal values and changes under different storage conditions (author's transl)].
    Sutor AH, Schorn P.
    Klin Padiatr; 1976 Nov 01; 188(6):499-507. PubMed ID: 1034164
    [Abstract] [Full Text] [Related]

  • 15. Coagulation studies: prothrombin time, partial thromboplastin time, bleeding time.
    Angelos MG, Hamilton GC.
    Emerg Med Clin North Am; 1986 Feb 01; 4(1):95-113. PubMed ID: 3512249
    [Abstract] [Full Text] [Related]

  • 16. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE, Meriwether E.
    Am J Vet Res; 1982 Aug 01; 43(8):1473-7. PubMed ID: 7103231
    [Abstract] [Full Text] [Related]

  • 17. [Laboratory controls of heparin therapy with thrombin time, partial thromboplastin time and activated recalcification time].
    Lutze G, Presser HJ, Urbahn H.
    Z Gesamte Inn Med; 1989 Apr 15; 44(8):235-40. PubMed ID: 2662657
    [Abstract] [Full Text] [Related]

  • 18. [Clinical value of a new method of therapeutic control of heparin].
    Pizzuto J, Garcia S, de la Paz Reyna M, Morales MR, Avilés A, Zavala B, Ponce L, Gaos C.
    Arch Inst Cardiol Mex; 1978 Apr 15; 48(2):373-86. PubMed ID: 666447
    [Abstract] [Full Text] [Related]

  • 19. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G, Lopot F.
    Z Urol Nephrol; 1984 Aug 15; 77(8):465-71. PubMed ID: 6495895
    [Abstract] [Full Text] [Related]

  • 20. Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient.
    Nowak G, Bucha E, Brauns I, Czerwinski R.
    Wien Klin Wochenschr; 1997 May 23; 109(10):354-8. PubMed ID: 9200807
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.